SPRO vs UBER · P/E 9.6, rev $48.0M vs P/E 18, rev $52.02B
Spero Therapeutics Inc (SPRO) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
SPRO currently screens at market cap $149.5M and trailing P/E 9.6. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the SPRO and UBER stock pages for the full models.
Not investment advice.